Patient Guide: A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 22 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05406401
Status: ACTIVE_NOT_RECRUITING
Condition: Lymphoma, Large B-Cell, Diffuse (DLBCL)
Phase: PHASE2

Find a Study Location Near You

This study is available at 22 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Victoria, British Columbia
  • Toronto, Ontario
  • Montreal, Quebec
  • • And 19 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily